Vimarsana
Biggest News Aggregation in the World

Paul Monagle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul Monagle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Monagle Today - Breaking & Trending Today

COVID Australia: Heparin nasal spray study could be 'game-changer' in preventing coronavirus - Vimarsana News

COVID Australia: Heparin nasal spray study could be 'game-changer' in preventing coronavirus

Every morning and every night, Professor Don Campbell sprays something in his nose. Could this be a “game-changer” in the fight against coronavirus?

COVID Australia: Heparin nasal spray study could be 'game-changer' in preventing coronavirus - Vimarsana News

COVID Australia: Heparin nasal spray study could be 'game-changer' in preventing coronavirus

Every morning and every night, Professor Don Campbell sprays something in his nose. Could this be a “game-changer” in the fight against coronavirus?

Mayo brothers secure €26,000 for 3 bulls at Christmas Cracker sale - Vimarsana News

Mayo brothers secure €26,000 for 3 bulls at Christmas Cracker sale

The Irish Charolais Cattle Society hosted its annual Christmas Cracker show and sale of bulls on Saturday (December 3) at Elphin Mart in Co. Roscommon.

Could a nasal spray protect you from COVID-19? - Vimarsana News

Could a nasal spray protect you from COVID-19?

25 May 2021 / Could a nasal spray protect you from COVID-19? Heparin might work as a short-term protective shield against COVID-19 when squirted up the nose but needs a trial to prove it. Nasal spray bottle plus lid. Credit: Jennifer A Smith / Getty Images. Researchers from the University of Melbourne have observed that spraying heparin on epithelial cells stops SARS-CoV-2 to infect them, at least in vitro (that is, in a petri dish). If the heparin spray had the same effect in humans, a simple, cheap nasal spray could help prevent COVID-19 infection. The research team is setting up a c...

Clot risk from AstraZeneca vaccine "twice" what originally thought, but research shows benefit still outweighs risk - Vimarsana News

Clot risk from AstraZeneca vaccine "twice" what originally thought, but research shows benefit still outweighs risk

Advertisement The federal government’s vaccine committee is unlikely to change its advisory against people under 50 having the AstraZeneca vaccine due to the risk of a rare blood clotting condition after considering new European research that suggests it is twice as prevalent as previously reported. But the study also forecasts the vaccine will still prevent many more deaths than it causes, even with relatively low levels of COVID-19 circulating in the community. One of the first vials of the AstraZeneca vaccine manufactured at Sequiris/CSL in Melbourne. New analysis from the European Me...